INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
The basis for the pathogenesis of systemic sclerosis (SS) is immune disorders that initiate inflammation, as well as vasculopathy with obvious microcirculatory disturbances, and generalized fibrosis. In SS, lung injury is due to an arterial lesion and/or a fibrotic process in the lung parenchyma and...
Saved in:
Main Author: | L. P. Ananyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2017-03-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2343 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE IMPORTANCE OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN EVALUATING THE EFFICACY OF RITUXIMAB IN PATIENTS WITH INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
by: O. A. Koneva, et al.
Published: (2018-11-01) -
Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01) -
Esophageal Diameter on High-Resolution Computed Tomography – a Potential Useful Marker for Interstitial Lung Disease Severity in Patients with Systemic Sclerosis
by: Anja Ljilja Posavec, et al.
Published: (2024-01-01) -
RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01) -
Ways to predict interstitial lung disease in patients with systemic sclerosis: results of an observational study
by: D. V. Khorolsky, et al.
Published: (2023-08-01)